Last updated on June 2019

rFVIIIFc (Elocta ) ITI Chart Review in Patients With Haemophilia A


Brief description of study

A 5-year chart review study of patients with haemophilia A with inhibitors treated with rFVIIIFc (Elocta) for immune tolerance induction.

Detailed Study Description

A 5-year multicenter, international, non- interventional, retrospective and prospective medical chart review study. Data will be collected from medical records for patients diagnosed with haemophilia A who have been, or who are currently, treated with rFVIIIFc for ITI . The study will be descriptive in nature and report on baseline characteristics, treatment and outcomes for patients who have been, or who are currently, treated with rFVIIIFc for ITI.

Clinical Study Identifier: NCT03951103

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.